Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 75

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 75
---
. For example, if you fail to instruct your bank, brokerage firm or other nominee to vote, it will have the same effect as a vote “AGAINST” the Merger Agreement Proposal. Proposal 2—The Adjournment Proposal.The affirmative vote, virtually or by proxy, of a majority of the votes properly cast by holders of shares of Enfusion Common Stock and Enfusion Class B Common Stock represented at the Special Meeting is required to approve the Adjournment Proposal. If you are an Enfusion Stockholder on the record date and (i) participate in the Special Meeting but fail to vote or (ii) mark your proxy card or voting instruction card to abstain, it will have no effect on the Adjournment Proposal. If you do not participate in the Special Meeting, virtually or by proxy, and do not instruct your bank, brokerage firm or other nominee how to vote your shares, it will have no effect on the Adjournment Proposal (assuming a quorum is present). As noted above, pursuant to the Support Agreements, each of the Significant Stockholders have agreed to vote all of the shares of Enfusion Common Stock and Enfusion Class B Common Stock held by them (representing in the aggregate approximately 46.4% of the total outstanding shares of Enfusion Common Stock and Enfusion Class B Common Stock as of the record date) in favor of the Merger Agreement Proposal. See the section titled “The Support Agreements.” How to Vote or Have Your Shares Voted Enfusion Stockholders of record may vote their shares of Enfusion Common Stock or Enfusion Class B Common Stock or submit a proxy to have their shares of Enfusion Common Stock or Enfusion Class B Common Stock voted at the Special Meeting in one of the following ways:

| • |     | Telephone: Enfusion Stockholders may submit their proxy by using a touch-tone telephone at 1-800-690-6903. Telephone voting is available 24 hours a day and will be accessible until 11:59 p.m., Eastern time, on April 16, 2025, the day before the Special Meeting. |

| • |     | Mail: Enfusion Stockholders may submit their proxy by properly completing, signing, dating and                                                                                                                                                          
 mailing their proxy card in the postage-paid envelope (if mailed in the United States) included with this Proxy Statement/Prospectus. Enfusion Stockholders who vote this way should mail the proxy card early enough so that it is received before the 
 date of the Special Meeting.